Aripiprazole-Induced Emotional Blunting

Introduction to Emotional Blunting

Aripiprazole can cause emotional blunting as a side effect, particularly manifesting as anxiety, agitation, and changes in emotional responsiveness, as reported by the European Society for Medical Oncology (ESMO) 1, 2

Emotional side effects can present as anxiety and agitation, which are commonly reported adverse effects, according to the European Society for Medical Oncology (ESMO) 2, 3
Headache and insomnia may contribute to emotional dysregulation, as noted by the European Society for Medical Oncology (ESMO) 2

The European Society for Medical Oncology (ESMO) Clinical Practice Guidelines state that aripiprazole may cause headache, agitation, anxiety, insomnia, dizziness, and drowsiness, which can contribute to emotional blunting 2, 3
The European Society for Medical Oncology (ESMO) lists these emotional side effects as potential adverse effects requiring monitoring, with a strength of evidence supporting the need for careful patient evaluation 1
Aripiprazole is less likely to cause extrapyramidal symptoms compared to first-generation antipsychotics, but emotional side effects remain a concern, as reported by the European Society for Medical Oncology (ESMO) 2

Patients with poor metabolization of cytochrome P450 2D6 may experience more frequent emotional side effects, according to the European Society for Medical Oncology (ESMO) 2
Older patients may be more sensitive to the medication's effects, including emotional side effects, as noted by the European Society for Medical Oncology (ESMO) 2

The European Society for Medical Oncology (ESMO) recommends considering dose reduction if emotional blunting occurs, as lower doses may reduce side effects while maintaining therapeutic benefit 2
Monitoring for drug-drug interactions, especially with cytochrome P450 2D6 and 3A4 inhibitors or inducers, is crucial to alter aripiprazole levels and minimize emotional side effects, as advised by the European Society for Medical Oncology (ESMO) 2, 3
Alternative medications should be considered if emotional blunting significantly impacts quality of life, according to the European Society for Medical Oncology (ESMO) 1